EMJ·3 min read·hard
MASLD and Hepatitis B Outcomes
A
anayamalik
✦AI Summary
A long-term study of adults with chronic hepatitis B found that concurrent metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases the risk of cardiovascular disease and extrahepatic cancers. The findings suggest that even mild liver involvement or normal enzyme levels do not necessarily mitigate these systemic health risks.
MASLD in chronic hepatitis B was associated with higher cardiovascular and extrahepatic cancer risks over 13.7 years.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in